Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis

Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis

Background/Aims: The addition of a fibrate to ursodeoxycholic acid (UDCA) is the standard treatment for asymptomatic primary biliary cholangitis (aPBC) with an incomplete response to UDCA. Among the fibrates, bezafibrate and fenofibrate increase the serum creatinine level and reduce the estimated...

Full description

Bibliographic Details
Main Authors: Kazufumi Dohmen, Shin-ya Onohara, Shigeru Harada
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2021-10-01
Series:The Korean Journal of Gastroenterology
Subjects:
primary biliary cholangitis
pemafibrate
bezafibrate
fenofibrate
glomerular filtration rate
creatinine
Online Access:https://www.kjg.or.kr/journal/view.html?uid=5756&vmd=Full

Internet

https://www.kjg.or.kr/journal/view.html?uid=5756&vmd=Full

Similar Items